Tag: medical cannabis

Paige Finkelstein Paige Finkelstein (1 Posts)

Contributing Writer

University of Miami Miller School of Medicine

Paige E. Finkelstein is a second-year medical student at University of Miami Miller School of Medicine’s combined MD/MPH program. She is the co-founder of health care startup ERinfo.me, a patent-pending mobile application. She received a bachelor of science in chemical engineering and biology from Massachusetts Institute of Technology in 2014 and hopes to one day pursue a residency in general surgery, then fellowship in surgical oncology.

medical cannabis

Why Floridians Should Vote Yes to Marijuana

Soon Floridians will be heading to the polls to vote in the upcoming election. Among important positions that will be voted upon, the decision to allow the sale of medical marijuana to qualified patients will be one of them. Currently there are 23 states that legalized the use of medical marijuana, including Massachusetts, New Jersey and New York. In the previous general election of 2014, Florida marginally missed legalizing marijuana: 57 percent of voters said yes, but it takes 60 percent to make it into law.


Ten Policy Issues to Watch in 2015

What I have learned along the way is that many people find policy boring. Maybe they associate it with clips of C-SPAN they watched in middle school civics class, or perhaps it evokes the frustration felt when yet another health policy dies a silent death on a Congressional floor, but whatever the reason, policy is ascribed as a responsibility solely for politicians. This presents a massive conundrum because our interests as future clinicians cannot be represented if we are not the ones speaking to policymakers.

medical cannabis

Medical Cannabis in Context: Brain Function

One of the most contentious issues in the debate on medical cannabis concerns the effect of medical cannabis on the brain. Understanding the harms of medical cannabis in relation to the harms produced by conditions which may be ameliorated by its use is vital to understanding its viability as a treatment. For example, the side effect of mild short term memory loss may be vastly outweighed by the boon of its anti-emetic and anti-nausea properties for a cancer patient. …

medical cannabis

Medical Cannabis Made Simple

Does cannabis work as a treatment for some symptoms or conditions? Yes. Has research been conducted to prove that? Yes, more than many people think. High-quality scientific evidence (in the United States and abroad) has been conducted on medical cannabis, showing its efficacy for varying symptoms and conditions, such as neuropathic pain and symptoms of multiple sclerosis, such as spasticity and sleep disturbance. Double-blinded placebo controlled studies and observational studies (including many case studies) have …

medical cannabis

Bias in the Media: Medical Cannabis and the Myth of Amotivational Syndrome

How much influence does the media have on your views of medical treatments? This article continues coverage of the myth of amotivational syndrome in relation to medical cannabis, this time from the perspective of bias in the media. As mentioned in previous articles of this series, it is important for future physicians to be aware of the facts and falsities about this treatment option. As medical cannabis gains both medical and public acceptance, blooming and …

medical cannabis

Medical Cannabis and the Myth of Amotivational Syndrome

Understanding the various opposing arguments to medical cannabis is important for future physicians and medical professionals. In the next few years, cannabis will likely become more widely accepted as an established medical treatment, and it is important to understand issues surrounding its use. Here, I outline one point of contention in the medical cannabis debate to increase understanding of medical cannabis and its relationship to patients. Long-term and sustained reduction of motivation, or increases in …

medical cannabis

Medical Cannabis: A Matter of Patients, Not Politics (Part 3/3)

This is the third and final installment in a three-part series on the topic of medical cannabis. Read the first article (medical cannabis law in the United States) here and the second article (cannabis as medicine and research limits) here. Organizational Support for Medical Cannabis Legalization Many organizations, including some of the most prestigious in the country, support the legalization of medical cannabis. Here is a partial list with their takes on the issue: New England Journal …

medical cannabis

Medical Cannabis: A Matter of Patients, Not Politics (Part 2/3)

This is the second installment in a three-part series on the topic of medical cannabis. Read the first article here. Cannabis as Medicine The health benefits of medical cannabis have been reported since 2737 B.C., when Chinese Emperor Shen Nung began to record its uses. These possible medical uses include the following: assists in decreasing nausea, vomiting, and pain, increases appetite, assists patients with insomnia, produces short-term reduction of intraocular eye pressure, has anti-anxiety properties, …

medical cannabis

Medical Cannabis: A Matter of Patients, Not Politics (Part 1/3)

Due to the potential of medical cannabis to provide relief to millions of patients in the United States, the need for state and federal governments to immediately increase research and legalize medical cannabis prescription is imperative. In this three-part series of articles, I will outline (1) the history of medical cannabis law in the United States, (2) information about cannabis as medicine and barriers that researchers and providers face in increasing access of this medication …

Arielle Gerard Arielle Gerard (7 Posts)

Contributing Writer and in-Training Staff Member

Albany Medical College

Arielle is currently a Class of 2017 MD candidate at Albany Medical College, and received her BA in Psychology from UCLA. She has a passion for advocacy and quality of life improvement in various fields, and is completing a Distinction in Advocacy in support of federal reclassification of cannabis, which will allow for an increase in cannabinoid research in the United States and may lead to increased safe access to whole-plant cannabis for patients who could potentially benefit from its use.